speb/financial-data huggingface dataset:
XBIO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -199875331.00
XBIO income_statement (annual, 2025-12-31) — Selling General And Administration: 2745509.00
XBIO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 615907.00
XBIO balance_sheet (annual, 2025-12-31) — Share Issued: 2293757.00
XBIO balance_sheet (quarterly, 2025-12-31) — Share Issued: 2293757.00
XBIO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 64787.00
XBIO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 13998.00
XBIO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 7395822.00
XBIO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 7395822.00
XBIO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 7394368.00
XBIO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 7394368.00
XBIO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
XBIO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
XBIO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
XBIO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
XBIO balance_sheet (annual, 2025-12-31) — Total Assets: 8363847.00
XBIO balance_sheet (quarterly, 2025-12-31) — Total Assets: 8363847.00
XBIO balance_sheet (annual, 2025-12-31) — Total Capitalization: 7395822.00
XBIO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 7395822.00
XBIO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 7395822.00
XBIO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 7395822.00
XBIO income_statement (annual, 2025-12-31) — Total Expenses: 5810993.00
XBIO income_statement (quarterly, 2025-12-31) — Total Expenses: 1389323.00
XBIO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 968025.00
XBIO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 968025.00
XBIO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 313921.00
XBIO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 313921.00
XBIO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
XBIO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
XBIO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -2834582.00
XBIO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -623027.00
XBIO balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 2701.00
XBIO balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 2701.00
XBIO balance_sheet (annual, 2025-12-31) — Treasury Stock: 5281180.00
XBIO balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 5281180.00
XBIO balance_sheet (annual, 2025-12-31) — Working Capital: 7081901.00
XBIO balance_sheet (quarterly, 2025-12-31) — Working Capital: 7081901.00
XBIO income_statement (quarterly, 2026-03-31) — +Operating Expense: 1309040.00
XBIO income_statement (quarterly, 2026-03-31) — +Total Revenue: 806923.00
XBIO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 558808.00
XBIO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 212306163.00
XBIO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 2291056.00
XBIO income_statement (quarterly, 2026-03-31) — Basic EPS: -0.20
XBIO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 7883632.00
XBIO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 3748.00
XBIO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 7347255.00
XBIO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 7347255.00
XBIO balance_sheet (quarterly, 2026-03-31) — Cash Financial: 7347255.00
XBIO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -536377.00
XBIO cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -9786.00
XBIO cash_flow (quarterly, 2026-03-31) — Change In Payable: -9786.00
XBIO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -9786.00
XBIO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -81521.00
XBIO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -91307.00
XBIO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -536377.00
XBIO balance_sheet (quarterly, 2026-03-31) — Common Stock: 2294.00
XBIO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 6949298.00
XBIO balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 399431.00
XBIO balance_sheet (quarterly, 2026-03-31) — Current Assets: 7595070.00
XBIO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 958239.00
XBIO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 2291056.00
XBIO income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.20
XBIO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -456382.00
XBIO income_statement (quarterly, 2026-03-31) — EBIT: -502117.00
XBIO income_statement (quarterly, 2026-03-31) — EBITDA: -502117.00
XBIO cash_flow (quarterly, 2026-03-31) — End Cash Position: 7347255.00
XBIO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -536377.00
XBIO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 253734.00
XBIO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 647597.00
XBIO income_statement (quarterly, 2026-03-31) — Interest Income: 45756.00
XBIO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 45756.00
XBIO cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 0.00
XBIO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 6949298.00
XBIO income_statement (quarterly, 2026-03-31) — Net Income: -456382.00
XBIO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -456382.00
XBIO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -456382.00
XBIO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -456382.00
XBIO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -456382.00
XBIO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -456382.00
XBIO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -456382.00
XBIO income_statement (quarterly, 2026-03-31) — Net Interest Income: 45756.00
XBIO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 45756.00
XBIO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 6950752.00
XBIO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -502117.00
XBIO income_statement (quarterly, 2026-03-31) — Normalized Income: -456382.00
XBIO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -536377.00
XBIO income_statement (quarterly, 2026-03-31) — Operating Income: -502117.00
XBIO income_statement (quarterly, 2026-03-31) — Operating Revenue: 806923.00
XBIO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 2291056.00
XBIO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 247815.00
XBIO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 253734.00
XBIO income_statement (quarterly, 2026-03-31) — Other Gand A: 647597.00
XBIO income_statement (quarterly, 2026-03-31) — Other Income Expense: -21.00
XBIO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 313921.00
XBIO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -21.00
XBIO balance_sheet (quarterly, 2026-03-31) — Payables: 558808.00
XBIO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 958239.00
XBIO balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 1454.00
XBIO balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 1454.00
XBIO income_statement (quarterly, 2026-03-31) — Pretax Income: -456382.00
XBIO income_statement (quarterly, 2026-03-31) — Research And Development: 661443.00
XBIO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -200331713.00
XBIO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 647597.00
XBIO balance_sheet (quarterly, 2026-03-31) — Share Issued: 2293757.00
XBIO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 11312.00
XBIO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 6950752.00
XBIO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 6949298.00
XBIO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
XBIO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
XBIO balance_sheet (quarterly, 2026-03-31) — Total Assets: 7908991.00
XBIO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 6950752.00
XBIO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 6950752.00
XBIO income_statement (quarterly, 2026-03-31) — Total Expenses: 1309040.00
XBIO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 958239.00
XBIO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 313921.00
XBIO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
XBIO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -502117.00
XBIO balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 2701.00
XBIO balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 5281180.00
XBIO balance_sheet (quarterly, 2026-03-31) — Working Capital: 6636831.00
XBIT balance_sheet (annual, 2021-12-31) — Accounts Receivable: 0.00
XBIT income_statement (annual, 2021-12-31) — Basic Average Shares: 30043380.00
XBIT income_statement (annual, 2021-12-31) — Basic EPS: -0.58
XBIT cash_flow (annual, 2021-12-31) — Cash Dividends Paid: -75003000.00
XBIT cash_flow (annual, 2021-12-31) — Change In Other Working Capital: 78646000.00
XBIT cash_flow (annual, 2021-12-31) — Changes In Account Receivables: 4113000.00
XBIT cash_flow (annual, 2021-12-31) — Common Stock Dividend Paid: -75003000.00
XBIT cash_flow (annual, 2021-12-31) — Common Stock Issuance: 0.00
XBIT income_statement (annual, 2021-12-31) — Cost Of Revenue: 5820000.00
XBIT balance_sheet (annual, 2021-12-31) — Current Deferred Assets: 0.00
XBIT income_statement (annual, 2021-12-31) — Diluted Average Shares: 30043380.00
XBIT income_statement (annual, 2021-12-31) — Diluted EPS: -0.58
XBIT cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: 0.00
XBIT income_statement (annual, 2021-12-31) — Gain On Sale Of Ppe: 0.00
XBIT balance_sheet (annual, 2021-12-31) — Gains Losses Not Affecting Retained Earnings: 1971000.00
XBIT income_statement (annual, 2021-12-31) — Gross Profit: 12574000.00
XBIT cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 0.00
XBIT cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 0.00
XBIT cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
XBIT cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 0.00
XBIT cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: 0.00
XBIT balance_sheet (annual, 2021-12-31) — Non Current Deferred Assets: 0.00
XBIT balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Assets: 0.00
XBIT balance_sheet (annual, 2021-12-31) — Other Equity Adjustments: 1971000.00
XBIT balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 0.00
XBIT balance_sheet (annual, 2021-12-31) — Prepaid Assets: 934000.00
XBIT cash_flow (annual, 2021-12-31) — Purchase Of Investment: 0.00
XBIT income_statement (annual, 2021-12-31) — Reconciled Cost Of Revenue: 5820000.00
XBIT balance_sheet (annual, 2021-12-31) — Restricted Cash: 0.00
XBIT cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
XBIT income_statement (annual, 2021-12-31) — Special Income Charges: 0.00
XBIT income_statement (annual, 2022-12-31) — +Operating Expense: 37849000.00
XBIT income_statement (annual, 2022-12-31) — +Total Revenue: 4010000.00
XBIT balance_sheet (annual, 2022-12-31) — Accounts Payable: 2408000.00
XBIT balance_sheet (annual, 2022-12-31) — Accrued Interest Receivable: 1216000.00
XBIT balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -16495000.00
XBIT income_statement (annual, 2022-12-31) — Basic Average Shares: 30439275.00
XBIT income_statement (annual, 2022-12-31) — Basic EPS: -1.08
XBIT cash_flow (annual, 2022-12-31) — Beginning Cash Position: 236983000.00
XBIT balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 24173000.00
XBIT cash_flow (annual, 2022-12-31) — Capital Expenditure: -585000.00
XBIT balance_sheet (annual, 2022-12-31) — Capital Stock: 267325000.00
XBIT balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 157306000.00
XBIT balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 217478000.00
XBIT cash_flow (annual, 2022-12-31) — Cash Dividends Paid: 0.00
XBIT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 0.00
XBIT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -63892000.00
XBIT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -14824000.00
XBIT cash_flow (annual, 2022-12-31) — Change In Account Payable: 357000.00
XBIT cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 229000.00
XBIT cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: 155000.00
XBIT cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -815000.00
XBIT cash_flow (annual, 2022-12-31) — Change In Payable: 512000.00
XBIT cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 741000.00
XBIT cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 334000.00
XBIT cash_flow (annual, 2022-12-31) — Change In Receivables: 7340000.00
XBIT cash_flow (annual, 2022-12-31) — Change In Tax Payable: 155000.00
XBIT cash_flow (annual, 2022-12-31) — Change In Working Capital: 7600000.00
XBIT cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 0.00
XBIT cash_flow (annual, 2022-12-31) — Changes In Cash: -78716000.00
XBIT balance_sheet (annual, 2022-12-31) — Common Stock: 267325000.00
XBIT cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: 0.00
XBIT balance_sheet (annual, 2022-12-31) — Common Stock Equity: 240402000.00
XBIT balance_sheet (annual, 2022-12-31) — Construction In Progress: 401000.00
XBIT income_statement (annual, 2022-12-31) — Cost Of Revenue: 651000.00
XBIT balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 1114000.00
XBIT balance_sheet (annual, 2022-12-31) — Current Assets: 219843000.00
XBIT balance_sheet (annual, 2022-12-31) — Current Liabilities: 4066000.00
XBIT cash_flow (annual, 2022-12-31) — Depreciation: 2614000.00
XBIT cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 2614000.00
XBIT cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 2614000.00
XBIT income_statement (annual, 2022-12-31) — Diluted Average Shares: 30439275.00
XBIT income_statement (annual, 2022-12-31) — Diluted EPS: -1.08
XBIT income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -32900000.00
XBIT income_statement (annual, 2022-12-31) — EBIT: -34490000.00
XBIT income_statement (annual, 2022-12-31) — EBITDA: -31876000.00
XBIT cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -961000.00
XBIT cash_flow (annual, 2022-12-31) — End Cash Position: 157306000.00
XBIT cash_flow (annual, 2022-12-31) — Financing Cash Flow: 0.00
XBIT cash_flow (annual, 2022-12-31) — Free Cash Flow: -15409000.00
XBIT income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -2800000.00
XBIT balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 826000.00
XBIT income_statement (annual, 2022-12-31) — General And Administrative Expense: 6305000.00
XBIT balance_sheet (annual, 2022-12-31) — Gross PPE: 42755000.00
XBIT income_statement (annual, 2022-12-31) — Gross Profit: 3359000.00
XBIT balance_sheet (annual, 2022-12-31) — Income Tax Payable: 55000.00
XBIT income_statement (annual, 2022-12-31) — Interest Income: 3823000.00
XBIT income_statement (annual, 2022-12-31) — Interest Income Non Operating: 3823000.00
XBIT balance_sheet (annual, 2022-12-31) — Invested Capital: 240402000.00
XBIT cash_flow (annual, 2022-12-31) — Investing Cash Flow: -63892000.00
XBIT balance_sheet (annual, 2022-12-31) — Land And Improvements: 1418000.00
XBIT balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 704000.00
XBIT cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 2800000.00
XBIT income_statement (annual, 2022-12-31) — Net Income: -32900000.00
XBIT income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -32900000.00
XBIT income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -32900000.00
XBIT income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -32900000.00
XBIT income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -32900000.00
XBIT cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -32900000.00
XBIT income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -32900000.00
XBIT income_statement (annual, 2022-12-31) — Net Interest Income: 3823000.00
XBIT cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -63307000.00
XBIT income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 3823000.00
XBIT balance_sheet (annual, 2022-12-31) — Net PPE: 26260000.00
XBIT cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -585000.00
XBIT balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 240402000.00
XBIT balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 59000.00
XBIT balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 59000.00
XBIT income_statement (annual, 2022-12-31) — Normalized EBITDA: -29076000.00
XBIT income_statement (annual, 2022-12-31) — Normalized Income: -30156000.00
XBIT cash_flow (annual, 2022-12-31) — Operating Cash Flow: -14824000.00
XBIT cash_flow (annual, 2022-12-31) — Operating Gains Losses: 2800000.00
XBIT income_statement (annual, 2022-12-31) — Operating Income: -34490000.00
XBIT income_statement (annual, 2022-12-31) — Operating Revenue: 4010000.00
XBIT balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 30439275.00
XBIT balance_sheet (annual, 2022-12-31) — Other Current Assets: 601000.00
XBIT balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 826000.00
XBIT income_statement (annual, 2022-12-31) — Other Gand A: 2390000.00
XBIT income_statement (annual, 2022-12-31) — Other Income Expense: -2921000.00
XBIT income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -121000.00
XBIT balance_sheet (annual, 2022-12-31) — Other Properties: 16059000.00
XBIT balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 60172000.00
XBIT balance_sheet (annual, 2022-12-31) — Payables: 2463000.00
XBIT balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 3577000.00
XBIT balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 489000.00
XBIT balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
XBIT income_statement (annual, 2022-12-31) — Pretax Income: -33588000.00
XBIT cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
XBIT balance_sheet (annual, 2022-12-31) — Properties: 0.00
XBIT cash_flow (annual, 2022-12-31) — Purchase Of Investment: -63307000.00
XBIT cash_flow (annual, 2022-12-31) — Purchase Of PPE: -585000.00
XBIT balance_sheet (annual, 2022-12-31) — Receivables: 1764000.00
XBIT income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 651000.00
XBIT income_statement (annual, 2022-12-31) — Reconciled Depreciation: 2614000.00
XBIT income_statement (annual, 2022-12-31) — Research And Development: 31544000.00
XBIT balance_sheet (annual, 2022-12-31) — Retained Earnings: -27749000.00
XBIT income_statement (annual, 2022-12-31) — Salaries And Wages: 3915000.00
XBIT income_statement (annual, 2022-12-31) — Selling General And Administration: 6305000.00
XBIT balance_sheet (annual, 2022-12-31) — Share Issued: 30439275.00
XBIT cash_flow (annual, 2022-12-31) — Stock Based Compensation: 5062000.00
XBIT balance_sheet (annual, 2022-12-31) — Stockholders Equity: 240402000.00
XBIT balance_sheet (annual, 2022-12-31) — Tangible Book Value: 240402000.00
XBIT income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -56000.00
XBIT income_statement (annual, 2022-12-31) — Tax Provision: -688000.00
XBIT income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.02
XBIT balance_sheet (annual, 2022-12-31) — Taxes Receivable: 548000.00
XBIT balance_sheet (annual, 2022-12-31) — Total Assets: 246103000.00
XBIT balance_sheet (annual, 2022-12-31) — Total Capitalization: 240402000.00
XBIT balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 240402000.00
XBIT income_statement (annual, 2022-12-31) — Total Expenses: 38500000.00
XBIT balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 5701000.00
XBIT balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 26260000.00
XBIT balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1635000.00
XBIT income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -34490000.00
XBIT balance_sheet (annual, 2022-12-31) — Total Tax Payable: 55000.00
XBIT income_statement (annual, 2022-12-31) — Total Unusual Items: -2800000.00
XBIT income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -2800000.00
XBIT balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 1576000.00
XBIT balance_sheet (annual, 2022-12-31) — Working Capital: 215777000.00
XBIT income_statement (annual, 2023-12-31) — +Operating Expense: 37510000.00
XBIT income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
XBIT balance_sheet (annual, 2023-12-31) — Accounts Payable: 2516000.00
XBIT balance_sheet (annual, 2023-12-31) — Accrued Interest Receivable: 860000.00
XBIT balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -18239000.00
XBIT income_statement (annual, 2023-12-31) — Basic Average Shares: 30438459.00
XBIT income_statement (annual, 2023-12-31) — Basic EPS: -0.81
XBIT cash_flow (annual, 2023-12-31) — Beginning Cash Position: 157306000.00
XBIT balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 24173000.00
XBIT cash_flow (annual, 2023-12-31) — Capital Expenditure: -362000.00
XBIT balance_sheet (annual, 2023-12-31) — Capital Stock: 271152000.00
XBIT balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 200023000.00
XBIT balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 200023000.00
XBIT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -9000.00
XBIT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 61497000.00
XBIT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -18725000.00
XBIT cash_flow (annual, 2023-12-31) — Change In Account Payable: 91000.00
XBIT cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 1895000.00
XBIT cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: 123000.00
XBIT cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -59000.00
XBIT cash_flow (annual, 2023-12-31) — Change In Payable: 214000.00
XBIT cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 2109000.00
XBIT cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -160000.00
XBIT cash_flow (annual, 2023-12-31) — Change In Receivables: 829000.00
XBIT cash_flow (annual, 2023-12-31) — Change In Tax Payable: 123000.00
XBIT cash_flow (annual, 2023-12-31) — Change In Working Capital: 2719000.00
XBIT cash_flow (annual, 2023-12-31) — Changes In Cash: 42763000.00
XBIT balance_sheet (annual, 2023-12-31) — Common Stock: 271152000.00
XBIT balance_sheet (annual, 2023-12-31) — Common Stock Equity: 218846000.00
XBIT balance_sheet (annual, 2023-12-31) — Construction In Progress: 469000.00
XBIT income_statement (annual, 2023-12-31) — Cost Of Revenue: 0.00
XBIT balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 2939000.00
XBIT balance_sheet (annual, 2023-12-31) — Current Assets: 201718000.00
XBIT balance_sheet (annual, 2023-12-31) — Current Liabilities: 6100000.00
XBIT cash_flow (annual, 2023-12-31) — Depreciation: 1744000.00
XBIT cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 1744000.00
XBIT cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1744000.00
XBIT income_statement (annual, 2023-12-31) — Diluted Average Shares: 30438459.00
XBIT income_statement (annual, 2023-12-31) — Diluted EPS: -0.81
XBIT income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -24557000.00
XBIT income_statement (annual, 2023-12-31) — EBIT: -24313000.00
XBIT income_statement (annual, 2023-12-31) — EBITDA: -22569000.00
XBIT cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -46000.00
XBIT cash_flow (annual, 2023-12-31) — End Cash Position: 200023000.00
XBIT cash_flow (annual, 2023-12-31) — Financing Cash Flow: -9000.00
XBIT cash_flow (annual, 2023-12-31) — Free Cash Flow: -19087000.00
XBIT income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 1893000.00
XBIT balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
XBIT income_statement (annual, 2023-12-31) — General And Administrative Expense: 4662000.00
XBIT balance_sheet (annual, 2023-12-31) — Gross PPE: 43136000.00
XBIT income_statement (annual, 2023-12-31) — Gross Profit: 0.00
XBIT cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 141000.00
XBIT balance_sheet (annual, 2023-12-31) — Income Tax Payable: 83000.00
XBIT income_statement (annual, 2023-12-31) — Interest Expense: 0.00
XBIT income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 0.00
XBIT income_statement (annual, 2023-12-31) — Interest Income: 10421000.00
XBIT income_statement (annual, 2023-12-31) — Interest Income Non Operating: 10421000.00
XBIT cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 0.00
XBIT balance_sheet (annual, 2023-12-31) — Interest Payable: 0.00
XBIT balance_sheet (annual, 2023-12-31) — Invested Capital: 218846000.00
XBIT cash_flow (annual, 2023-12-31) — Investing Cash Flow: 61497000.00
XBIT cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
XBIT balance_sheet (annual, 2023-12-31) — Land And Improvements: 1418000.00
XBIT balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 709000.00
XBIT cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -1893000.00
XBIT income_statement (annual, 2023-12-31) — Net Income: -24557000.00
XBIT income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -24557000.00
XBIT income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -24557000.00
XBIT income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -24557000.00
XBIT income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -24557000.00
XBIT cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -24557000.00
XBIT income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -24557000.00
XBIT income_statement (annual, 2023-12-31) — Net Interest Income: 10421000.00
XBIT cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 61859000.00
XBIT cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
XBIT income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 10421000.00
XBIT cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -14000.00
XBIT balance_sheet (annual, 2023-12-31) — Net PPE: 24897000.00
XBIT cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -362000.00
XBIT cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 0.00
XBIT balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 218846000.00
XBIT balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 0.00
XBIT balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 0.00
XBIT income_statement (annual, 2023-12-31) — Normalized EBITDA: -24462000.00
XBIT income_statement (annual, 2023-12-31) — Normalized Income: -26052470.00
XBIT cash_flow (annual, 2023-12-31) — Operating Cash Flow: -18725000.00
XBIT cash_flow (annual, 2023-12-31) — Operating Gains Losses: -1893000.00
XBIT income_statement (annual, 2023-12-31) — Operating Income: -37510000.00
XBIT income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
XBIT balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 30436964.00
XBIT balance_sheet (annual, 2023-12-31) — Other Current Assets: 760000.00
XBIT income_statement (annual, 2023-12-31) — Other Gand A: 2916000.00
XBIT income_statement (annual, 2023-12-31) — Other Income Expense: 2776000.00
XBIT income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 883000.00
XBIT balance_sheet (annual, 2023-12-31) — Other Properties: 16367000.00
XBIT balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 0.00
XBIT balance_sheet (annual, 2023-12-31) — Payables: 2599000.00
XBIT balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 5538000.00
XBIT balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 562000.00
XBIT balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
XBIT income_statement (annual, 2023-12-31) — Pretax Income: -24313000.00
XBIT cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 5000.00
XBIT balance_sheet (annual, 2023-12-31) — Properties: 0.00
XBIT cash_flow (annual, 2023-12-31) — Purchase Of PPE: -362000.00
XBIT balance_sheet (annual, 2023-12-31) — Receivables: 935000.00
XBIT income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 0.00
XBIT income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1744000.00
XBIT income_statement (annual, 2023-12-31) — Research And Development: 32848000.00
XBIT balance_sheet (annual, 2023-12-31) — Retained Earnings: -52306000.00
XBIT income_statement (annual, 2023-12-31) — Salaries And Wages: 1746000.00
XBIT cash_flow (annual, 2023-12-31) — Sale Of Investment: 61859000.00
XBIT income_statement (annual, 2023-12-31) — Selling General And Administration: 4662000.00
XBIT balance_sheet (annual, 2023-12-31) — Share Issued: 30436964.00
XBIT cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 0.00
XBIT cash_flow (annual, 2023-12-31) — Stock Based Compensation: 3262000.00
XBIT balance_sheet (annual, 2023-12-31) — Stockholders Equity: 218846000.00
XBIT balance_sheet (annual, 2023-12-31) — Tangible Book Value: 218846000.00
XBIT income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 397530.00
XBIT income_statement (annual, 2023-12-31) — Tax Provision: 244000.00
XBIT income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
XBIT balance_sheet (annual, 2023-12-31) — Taxes Receivable: 75000.00
XBIT balance_sheet (annual, 2023-12-31) — Total Assets: 226615000.00
XBIT balance_sheet (annual, 2023-12-31) — Total Capitalization: 218846000.00
XBIT balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 218846000.00
XBIT income_statement (annual, 2023-12-31) — Total Expenses: 37510000.00
XBIT balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 7769000.00
XBIT balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 24897000.00
XBIT balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1669000.00
XBIT income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -37510000.00
XBIT balance_sheet (annual, 2023-12-31) — Total Tax Payable: 83000.00
XBIT income_statement (annual, 2023-12-31) — Total Unusual Items: 1893000.00
XBIT income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 1893000.00
XBIT balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 1669000.00
XBIT balance_sheet (annual, 2023-12-31) — Working Capital: 195618000.00
XBIT income_statement (quarterly, 2024-09-30) — Basic Average Shares: 30472557.00
XBIT income_statement (quarterly, 2024-09-30) — Basic EPS: -0.16
XBIT balance_sheet (quarterly, 2024-09-30) — Current Debt: 10000000.00
XBIT balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 10000000.00
XBIT income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 30472557.00
XBIT income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.16
XBIT cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
XBIT balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 10000000.00
XBIT cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 64000.00
XBIT cash_flow (quarterly, 2024-09-30) — Short Term Debt Issuance: 0.00
XBIT balance_sheet (quarterly, 2024-09-30) — Total Debt: 10000000.00
XBIT income_statement (annual, 2024-12-31) — +Operating Expense: 42471000.00
XBIT income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
XBIT balance_sheet (annual, 2024-12-31) — Accounts Payable: 2223000.00
XBIT balance_sheet (annual, 2024-12-31) — Accrued Interest Receivable: 700000.00
XBIT balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -19985000.00
XBIT balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -19985000.00
XBIT income_statement (annual, 2024-12-31) — Basic Average Shares: 30460980.00
XBIT income_statement (annual, 2024-12-31) — Basic EPS: -1.26
XBIT cash_flow (annual, 2024-12-31) — Beginning Cash Position: 200023000.00
XBIT balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 24173000.00
XBIT cash_flow (annual, 2024-12-31) — Capital Expenditure: -1304000.00
XBIT cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -84000.00
XBIT balance_sheet (annual, 2024-12-31) — Capital Stock: 273105000.00
XBIT balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 172677000.00
XBIT balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 172677000.00
XBIT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 10450000.00
XBIT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -1304000.00
XBIT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -30963000.00
XBIT cash_flow (annual, 2024-12-31) — Change In Account Payable: -364000.00
XBIT cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -877000.00
XBIT cash_flow (annual, 2024-12-31) — Change In Income Tax Payable: -24000.00
XBIT cash_flow (annual, 2024-12-31) — Change In Payable: -388000.00
XBIT cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -1265000.00
XBIT cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -271000.00
XBIT cash_flow (annual, 2024-12-31) — Change In Receivables: 77000.00
XBIT cash_flow (annual, 2024-12-31) — Change In Tax Payable: -24000.00
XBIT cash_flow (annual, 2024-12-31) — Change In Working Capital: -1459000.00
XBIT cash_flow (annual, 2024-12-31) — Changes In Cash: -21817000.00
XBIT balance_sheet (annual, 2024-12-31) — Common Stock: 273105000.00
XBIT balance_sheet (annual, 2024-12-31) — Common Stock Equity: 182268000.00
XBIT balance_sheet (annual, 2024-12-31) — Construction In Progress: 1705000.00
XBIT balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 1705000.00
XBIT balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 2021000.00
XBIT balance_sheet (annual, 2024-12-31) — Current Assets: 174567000.00
XBIT balance_sheet (annual, 2024-12-31) — Current Debt: 10250000.00
XBIT balance_sheet (quarterly, 2024-12-31) — Current Debt: 10250000.00
XBIT balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 10250000.00
XBIT balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 10250000.00
XBIT balance_sheet (annual, 2024-12-31) — Current Liabilities: 15105000.00
XBIT cash_flow (annual, 2024-12-31) — Depreciation: 1745000.00
XBIT cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1745000.00
XBIT cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1745000.00
XBIT income_statement (annual, 2024-12-31) — Diluted Average Shares: 30460980.00
XBIT income_statement (annual, 2024-12-31) — Diluted EPS: -1.26
XBIT income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -38531000.00
XBIT income_statement (annual, 2024-12-31) — EBIT: -37756000.00
XBIT income_statement (annual, 2024-12-31) — EBITDA: -36011000.00
XBIT cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -5529000.00
XBIT cash_flow (annual, 2024-12-31) — End Cash Position: 172677000.00
XBIT cash_flow (annual, 2024-12-31) — Financing Cash Flow: 10450000.00
XBIT cash_flow (annual, 2024-12-31) — Free Cash Flow: -32267000.00
XBIT income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -5529000.00
XBIT income_statement (annual, 2024-12-31) — General And Administrative Expense: 4714000.00
XBIT balance_sheet (annual, 2024-12-31) — Gross PPE: 44511000.00
XBIT cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 87000.00
XBIT balance_sheet (annual, 2024-12-31) — Income Tax Payable: 0.00
XBIT income_statement (annual, 2024-12-31) — Interest Expense: 807000.00
XBIT income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 807000.00
XBIT income_statement (annual, 2024-12-31) — Interest Income: 9812000.00
XBIT income_statement (annual, 2024-12-31) — Interest Income Non Operating: 9812000.00
XBIT cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 400000.00
XBIT balance_sheet (annual, 2024-12-31) — Interest Payable: 404000.00
XBIT balance_sheet (quarterly, 2024-12-31) — Interest Payable: 404000.00
XBIT balance_sheet (annual, 2024-12-31) — Invested Capital: 192518000.00
XBIT cash_flow (annual, 2024-12-31) — Investing Cash Flow: -1304000.00
XBIT cash_flow (annual, 2024-12-31) — Issuance Of Debt: 10250000.00
XBIT cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 250000.00
XBIT balance_sheet (annual, 2024-12-31) — Land And Improvements: 1418000.00
XBIT balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 1418000.00
XBIT balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 724000.00
XBIT balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 724000.00
XBIT cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 5529000.00
XBIT income_statement (annual, 2024-12-31) — Net Income: -38531000.00
XBIT income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -38531000.00
XBIT income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -38531000.00
XBIT income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -38531000.00
XBIT income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -38531000.00
XBIT cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -38531000.00
XBIT income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -38531000.00
XBIT income_statement (annual, 2024-12-31) — Net Interest Income: 9005000.00
XBIT cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
XBIT cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
XBIT cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 10250000.00
XBIT income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 9005000.00
XBIT balance_sheet (annual, 2024-12-31) — Net PPE: 24526000.00
XBIT cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -1304000.00
XBIT cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 10250000.00
XBIT balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 182268000.00
XBIT balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 0.00
XBIT balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 0.00
XBIT balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 0.00
XBIT balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 0.00
XBIT income_statement (annual, 2024-12-31) — Normalized EBITDA: -30482000.00
XBIT income_statement (annual, 2024-12-31) — Normalized Income: -33006423.20
XBIT cash_flow (annual, 2024-12-31) — Operating Cash Flow: -30963000.00
XBIT cash_flow (annual, 2024-12-31) — Operating Gains Losses: 5529000.00
XBIT income_statement (annual, 2024-12-31) — Operating Income: -42471000.00
XBIT income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
XBIT balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 30487731.00
XBIT balance_sheet (annual, 2024-12-31) — Other Current Assets: 1032000.00
XBIT balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 10250000.00
XBIT balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 10250000.00
XBIT income_statement (annual, 2024-12-31) — Other Gand A: 2564000.00
XBIT income_statement (annual, 2024-12-31) — Other Income Expense: -5097000.00
XBIT income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 432000.00
XBIT balance_sheet (annual, 2024-12-31) — Other Properties: 16491000.00
XBIT balance_sheet (annual, 2024-12-31) — Payables: 2223000.00
XBIT balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 4244000.00
XBIT balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 611000.00
XBIT balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 611000.00
XBIT balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
XBIT income_statement (annual, 2024-12-31) — Pretax Income: -38563000.00
XBIT cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 200000.00
XBIT cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 33000.00
XBIT balance_sheet (annual, 2024-12-31) — Properties: 0.00
XBIT cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1304000.00
XBIT balance_sheet (annual, 2024-12-31) — Receivables: 858000.00
XBIT income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1745000.00
XBIT income_statement (annual, 2024-12-31) — Research And Development: 37757000.00
XBIT balance_sheet (annual, 2024-12-31) — Retained Earnings: -90837000.00
XBIT income_statement (annual, 2024-12-31) — Salaries And Wages: 2150000.00
XBIT cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
XBIT cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 0.00
XBIT income_statement (annual, 2024-12-31) — Selling General And Administration: 4714000.00
XBIT balance_sheet (annual, 2024-12-31) — Share Issued: 30487731.00
XBIT cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 10250000.00
XBIT cash_flow (quarterly, 2024-12-31) — Short Term Debt Issuance: 250000.00
XBIT cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1753000.00
XBIT balance_sheet (annual, 2024-12-31) — Stockholders Equity: 182268000.00
XBIT balance_sheet (annual, 2024-12-31) — Tangible Book Value: 182268000.00
XBIT income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -4423.20
XBIT income_statement (annual, 2024-12-31) — Tax Provision: -32000.00
XBIT income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
XBIT balance_sheet (annual, 2024-12-31) — Taxes Receivable: 158000.00
XBIT balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 158000.00
XBIT balance_sheet (annual, 2024-12-31) — Total Assets: 199093000.00
XBIT balance_sheet (annual, 2024-12-31) — Total Capitalization: 182268000.00
XBIT balance_sheet (annual, 2024-12-31) — Total Debt: 10250000.00
XBIT balance_sheet (quarterly, 2024-12-31) — Total Debt: 10250000.00
XBIT balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 182268000.00
XBIT income_statement (annual, 2024-12-31) — Total Expenses: 42471000.00
XBIT balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 16825000.00
XBIT balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 24526000.00
XBIT balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1720000.00
XBIT income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -42471000.00
XBIT balance_sheet (annual, 2024-12-31) — Total Tax Payable: 0.00
XBIT income_statement (annual, 2024-12-31) — Total Unusual Items: -5529000.00
XBIT income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -5529000.00
XBIT balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 1720000.00
XBIT balance_sheet (annual, 2024-12-31) — Working Capital: 159462000.00
XBIT income_statement (quarterly, 2025-03-31) — +Operating Expense: 13550000.00
XBIT income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
XBIT balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1100000.00
XBIT balance_sheet (quarterly, 2025-03-31) — Accrued Interest Receivable: 480000.00
XBIT income_statement (quarterly, 2025-03-31) — Basic Average Shares: 30487731.00
XBIT income_statement (quarterly, 2025-03-31) — Basic EPS: -0.36
XBIT cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 172677000.00
XBIT balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 21049000.00
XBIT cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -94000.00
XBIT balance_sheet (quarterly, 2025-03-31) — Capital Stock: 276434000.00
XBIT balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 155897000.00
XBIT balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 155897000.00
XBIT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -10250000.00
XBIT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -94000.00
XBIT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -6720000.00
XBIT cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -1125000.00
XBIT cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 1671000.00
XBIT cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: 29000.00
XBIT cash_flow (quarterly, 2025-03-31) — Change In Payable: -1096000.00
XBIT cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 575000.00
XBIT cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -118000.00
XBIT cash_flow (quarterly, 2025-03-31) — Change In Receivables: 220000.00
XBIT cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: 29000.00
XBIT cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 677000.00
XBIT cash_flow (quarterly, 2025-03-31) — Changes In Cash: -17064000.00
XBIT balance_sheet (quarterly, 2025-03-31) — Common Stock: 276434000.00
XBIT balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 174713000.00
XBIT cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
XBIT balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 4303000.00
XBIT balance_sheet (quarterly, 2025-03-31) — Current Assets: 157685000.00
XBIT balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 5410000.00
XBIT cash_flow (quarterly, 2025-03-31) — Depreciation: 442000.00
XBIT cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 442000.00
XBIT cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 442000.00
XBIT income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 30487731.00
XBIT income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.36
XBIT income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -10884000.00
XBIT income_statement (quarterly, 2025-03-31) — EBIT: -10767000.00
XBIT income_statement (quarterly, 2025-03-31) — EBITDA: -10325000.00
XBIT cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 284000.00
XBIT cash_flow (quarterly, 2025-03-31) — End Cash Position: 155897000.00
XBIT cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -10250000.00
XBIT cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -6814000.00
XBIT income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 284000.00
XBIT income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1931000.00
XBIT balance_sheet (quarterly, 2025-03-31) — Gross PPE: 24179000.00
XBIT balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 7000.00
XBIT income_statement (quarterly, 2025-03-31) — Interest Expense: 88000.00